The Atrial Fibrillation in Turkey: Epidemiologic Registry (AFTER)

Basit Öğe Kaydı
dc.contributor.authorErtas, Faruk
dc.contributor.authorEren, Nihan Kahya
dc.contributor.authorKaya, Hasan
dc.contributor.authorAribas, Alpay
dc.contributor.authorAcar, Goksel
dc.contributor.authorKanadasi, Mehmet
dc.contributor.authorGedik, Selcuk
dc.date.accessioned2024-04-24T17:27:56Z
dc.date.available2024-04-24T17:27:56Z
dc.date.issued2013
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground: AFTER (Atrial Fibrillation in Turkey: Epidemiologic Registry) is a prospective, multicenter study designed with the aim of describing the prevalence and epidemiology of AF practice in Turkey. This study aims to evaluate stroke risk in non-valvular atrial fibrillation (AF) and anticoagulant drug utilization within conformity to AF guidelines. Methods: Patients were recruited in 17 referral hospitals reflecting all the population of 7 geographical regions of Turkey. 2242 consecutive patients who had been admitted with AF on ECG were included in the study. 1745 of these patients, who had non-valvular AF, were included in the statistical evaluation. Stroke risk was evaluated with the CHA(2)DS(2)-VASc score. Results: The average age of participants was determined to be 69.2 +/- 11.5 years (56% female). Persistent-permanent AF was found to be the most common type of non-valvular AF (78%). The most common comorbid disorder was hypertension (73%). It was found that oral anticoagulant therapy was used by 40% of all patients, 37% of whom had effective INR (2.0-3.0). Upon multivariate analysis, age was found to be the only independent predictor of stroke among the variables' effects on thromboembolic events that created CHA2DS2-VASc abbreviations (OR 1.026, p < 0.001). Conclusions: These results suggest that stroke risk scores should be thoroughly heeded based on guidelines, and that anticoagulation must be applied according to their guidance.en_US
dc.identifier.doi10.5603/CJ.a2013.0055
dc.identifier.endpage452en_US
dc.identifier.issn1897-5593
dc.identifier.issn1898-018X
dc.identifier.issue4en_US
dc.identifier.pmid23677730
dc.identifier.startpage447en_US
dc.identifier.urihttps://doi.org/10.5603/CJ.a2013.0055
dc.identifier.urihttps://hdl.handle.net/11468/20261
dc.identifier.volume20en_US
dc.identifier.wosWOS:000324268900016
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherVia Medicaen_US
dc.relation.ispartofCardiology Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAtrial Fibrillationen_US
dc.subjectStrokeen_US
dc.subjectAnticoagulanten_US
dc.subjectEpidemiologyen_US
dc.titleThe Atrial Fibrillation in Turkey: Epidemiologic Registry (AFTER)en_US
dc.titleThe Atrial Fibrillation in Turkey: Epidemiologic Registry (AFTER)
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu